Group One Trading’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-52,713
| Closed | -$3.81M | – | 8303 |
|
|
2026
Q1 | $3.59M | Buy |
+52,713
| New | +$3.73M | 0.01% | 1561 |
|
|
2025
Q4 | – | Sell |
-113,271
| Closed | -$8.23M | – | 8956 |
|
|
2025
Q3 | $6.95M | Buy |
113,271
+105,656
| +1,387% | +$5.5M | 0.01% | 1199 |
|
|
2025
Q2 | $372K | Buy |
7,615
+7,547
| +11,099% | +$358K | ﹤0.01% | 3722 |
|
|
2025
Q1 | $3.46K | Sell |
68
-393
| -85% | -$19.6K | ﹤0.01% | 6795 |
|
|
2024
Q4 | $20.8K | Buy |
+461
| New | +$19.7K | ﹤0.01% | 5655 |
|
|
2024
Q2 | – | Sell |
-16,306
| Closed | -$528K | – | 7334 |
|
|
2024
Q1 | $474K | Buy |
16,306
+15,938
| +4,331% | +$446K | ﹤0.01% | 2795 |
|
|
2023
Q4 | $10.1K | Sell |
368
-2,689
| -88% | -$61.5K | ﹤0.01% | 6189 |
|
|
2023
Q3 | $68.5K | Sell |
3,057
-1,233
| -29% | -$45.9K | ﹤0.01% | 4809 |
|
|
2023
Q2 | $174K | Buy |
4,290
+2,136
| +99% | +$105K | ﹤0.01% | 4084 |
|
|
2023
Q1 | $104K | Buy |
2,154
+1,868
| +653% | +$85.4K | ﹤0.01% | 4275 |
|
|
2022
Q4 | $10.9K | Buy |
286
+113
| +65% | +$4.7K | ﹤0.01% | 5991 |
|
|
2022
Q3 | $9K | Buy |
+173
| New | +$8.48K | ﹤0.01% | 6568 |
|
|
2022
Q2 | – | Sell |
-5,000
| Closed | -$175K | – | 8382 |
|
|
2022
Q1 | $187K | Buy |
+5,000
| New | +$193K | ﹤0.01% | 4863 |
|
|
2020
Q4 | – | Sell |
-15,390
| Closed | -$907K | – | 6902 |
|
|
2020
Q3 | $719K | Sell |
15,390
-6,184
| -29% | -$304K | ﹤0.01% | 2519 |
|
|
2020
Q2 | $1.09M | Sell |
21,574
-1,107
| -5% | -$54.4K | 0.01% | 1940 |
|
|
2020
Q1 | $1.01M | Buy |
+22,681
| New | +$1.14M | 0.01% | 1512 |
|
|
2019
Q1 | – | Sell |
-24,694
| Closed | -$829K | – | 5258 |
|
|
2018
Q4 | $848K | Buy |
24,694
+15,592
| +171% | +$561K | 0.01% | 1620 |
|
|
2018
Q3 | $428K | Sell |
9,102
-26,921
| -75% | -$1.11M | ﹤0.01% | 2412 |
|
|
2018
Q2 | $1.22M | Sell |
36,023
-7,201
| -17% | -$225K | 0.01% | 1527 |
|
|
2018
Q1 | $1.17M | Sell |
43,224
-526,149
| -92% | -$13.3M | 0.01% | 1391 |
|
|
2017
Q4 | $9.5M | Buy |
569,373
+478,635
| +527% | +$8.1M | 0.07% | 359 |
|
|
2017
Q3 | $1.82M | Buy |
90,738
+77,023
| +562% | +$1.51M | 0.02% | 1114 |
|
|
2017
Q2 | $251K | Sell |
13,715
-211,906
| -94% | -$2.86M | ﹤0.01% | 2472 |
|
|
2017
Q1 | $2.22M | Buy |
225,621
+147,865
| +190% | +$1.79M | 0.03% | 800 |
|
|
2016
Q4 | $848K | Buy |
+77,756
| New | +$816K | 0.01% | 1425 |
|
|
2016
Q3 | – | Sell |
-47,562
| Closed | -$387K | – | 4831 |
|
|
2016
Q2 | $334K | Buy |
47,562
+20,423
| +75% | +$150K | ﹤0.01% | 2027 |
|
|
2016
Q1 | $175K | Sell |
27,139
-50,621
| -65% | -$879K | ﹤0.01% | 2413 |
|
|
2015
Q4 | $2.52M | Buy |
77,760
+74,778
| +2,508% | +$2.2M | 0.03% | 722 |
|
|
2015
Q3 | $80K | Sell |
2,982
-20,624
| -87% | -$882K | ﹤0.01% | 3209 |
|
|
2015
Q2 | $1.14M | Buy |
23,606
+5,519
| +31% | +$322K | 0.02% | 1123 |
|
|
2015
Q1 | $1.1M | Buy |
18,087
+10,712
| +145% | +$654K | 0.02% | 1010 |
|
|
2014
Q4 | $382K | Buy |
+7,375
| New | +$325K | 0.01% | 1768 |
|
Other funds holding PTCT
RI
JT
Group One Trading's PTCT Position: Q2 2026 in Review
Group One Trading sold out of PTC Therapeutics (PTCT) in Q2 2026, closing a stake of 52,713 shares — an estimated $3.81M sold.
Group One Trading first reported a position in PTCT in Q4 2014 and held it in 32 quarters. The position peaked at $9.5M in Q4 2017. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.
- Group One Trading reported no remaining PTC Therapeutics position as of Q2 2026 after selling out during the quarter.
- Group One Trading sold 52,713 PTC Therapeutics shares in Q2 2026, an estimated $3.81M.
- Group One Trading first reported a position in PTC Therapeutics in Q4 2014 and held it in 32 quarters.
- Group One Trading's PTC Therapeutics position peaked at $9.5M in Q4 2017.
- 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.
Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.